Tsutomu Takeuchi

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
   2022/11/10 by Josef S Smolen, Robert B M Landewé, Robert Landewé +63 · 51 citations
   Medicine · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Biosimilars and Bioanalytical Methods #Hemophilia Treatment and Research
2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
   2020/01/22 by Josef S Smolen, Robert Landewé, Robert B M Landewé +62 · 32 citations
   Medicine · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Biosimilars and Bioanalytical Methods #Systemic Lupus Erythematosus Research
3. Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study
   2015/12/16 by Tsutomu Takeuchi, Yoshiya Tanaka, Manabu Iwasaki +3 · 26 citations
   Medicine · Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Connective Tissue Growth Factor Research #Psoriasis: Treatment and Pathogenesis
4. AXENIC CULTIVATION OF ENTAMOEBA DISPAR IN NEWLY DESIGNED YEAST EXTRACT–IRON–GLUCONIC ACID–DIHYRDOXYACETONE–SERUM MEDIUM
   2005/02/01 by Seiki Kobayashi, Eiko Imai, Ali Haghighi +4 · 1 citation
   Medicine · Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology · #Amoebic Infections and Treatments #Parasitic Infections and Diagnostics #Legionella and Acanthamoeba research